In addition to his clinical responsibilities, Dr. Jasmin conducts research on the anatomical, cellular and molecular mechanisms of pain, nerve injury and fibromyalgia and currently administers four groundbreaking projects for the National Institutes of Health. Under this mantle, he led one the first groups to successfully apply RNAi in vivo for the study of pain. Dr. Jasmin’s other NIH studies include the investigation of gene therapy for pain, cortical modulation of pain behavior in humans, and biochemical anomalies in fibromyalgia.